SCP
MRNA icon

Shorepoint Capital Partners’s Moderna MRNA Stock Holding History

Shorepoint Capital Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,888
Closed -$586K – 100
2023
Q4 		$586K Sell
5,888
-93
-2% -$7.82K 0.16% 81
2023
Q3 		$618K Sell
5,981
-240
-4% -$26.8K 0.18% 83
2023
Q2 		$756K Sell
6,221
-200
-3% -$26.7K 0.21% 86
2023
Q1 		$986K Buy
6,421
+585
+10% +$96.5K 0.28% 85
2022
Q4 		$1.05M Buy
+5,836
New +$954K 0.29% 86

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Shorepoint Capital Partners's MRNA Position: Q1 2024 in Review

Shorepoint Capital Partners sold out of Moderna (MRNA) in Q1 2024, closing a stake of 5,888 shares — an estimated $586K sold.

Shorepoint Capital Partners first reported a position in MRNA in Q4 2022 and held it in 5 quarters. The position peaked at $1.05M in Q4 2022. 902 funds tracked by Wall St. Rank hold MRNA as of Q1 2024.

  • Shorepoint Capital Partners reported no remaining Moderna position as of Q1 2024 after selling out during the quarter.
  • Shorepoint Capital Partners sold 5,888 Moderna shares in Q1 2024, an estimated $586K.
  • Shorepoint Capital Partners first reported a position in Moderna in Q4 2022 and held it in 5 quarters.
  • Shorepoint Capital Partners's Moderna position peaked at $1.05M in Q4 2022.
  • 902 funds tracked by Wall St. Rank held Moderna as of Q1 2024.

Based on Shorepoint Capital Partners's 13F filing for Q1 2024, filed 14 May 2024.